Hospital do Divino Espírito Santo de Ponta Delgada, Serviço de Pediatria, Ilha de São Miguel, Portugal.
Universidade do Porto, Instituto de Ciências Biomédicas Abel Salazar, Porto, Portugal.
J Bras Nefrol. 2024 Apr 29;46(3):e20240012. doi: 10.1590/2175-8239-JBN-2024-0012en. eCollection 2024.
Acute kidney injury (AKI) is an abrupt deterioration of kidney function. The incidence of pediatric AKI is increasing worldwide, both in critically and non-critically ill settings. We aimed to characterize the presentation, etiology, evolution, and outcome of AKI in pediatric patients admitted to a tertiary care center.
We performed a retrospective observational single-center study of patients aged 29 days to 17 years and 365 days admitted to our Pediatric Nephrology Unit from January 2012 to December 2021, with the diagnosis of AKI. AKI severity was categorized according to Kidney Disease Improving Global Outcomes (KDIGO) criteria. The outcomes considered were death or sequelae (proteinuria, hypertension, or changes in renal function at 3 to 6 months follow-up assessments).
Forty-six patients with a median age of 13.0 (3.5-15.5) years were included. About half of the patients (n = 24, 52.2%) had an identifiable risk factor for the development of AKI. Thirteen patients (28.3%) were anuric, and all of those were categorized as AKI KDIGO stage 3 (p < 0.001). Almost one quarter (n = 10, 21.7%) of patients required renal replacement therapy. Approximately 60% of patients (n = 26) had at least one sequelae, with proteinuria being the most common (n = 15, 38.5%; median (P25-75) urinary protein-to-creatinine ratio 0.30 (0.27-0.44) mg/mg), followed by reduced glomerular filtration rate (GFR) (n = 11, 27.5%; median (P25-75) GFR 75 (62-83) mL/min/1.73 m2).
Pediatric AKI is associated with substantial morbidity, with potential for proteinuria development and renal function impairment and a relevant impact on long-term prognosis.
急性肾损伤 (AKI) 是肾功能的突然恶化。在危重症和非危重症环境中,全世界儿科 AKI 的发病率都在上升。我们旨在描述在我们的儿科肾脏病学病房入院的儿科患者 AKI 的表现、病因、演变和结局。
我们进行了一项回顾性观察性单中心研究,纳入了 2012 年 1 月至 2021 年 12 月期间年龄在 29 天至 17 岁和 365 天的患者,诊断为 AKI。根据肾脏病改善全球结果 (KDIGO) 标准对 AKI 的严重程度进行分类。考虑的结局是死亡或后遗症(蛋白尿、高血压或在 3 至 6 个月随访评估时肾功能改变)。
共纳入 46 名中位年龄为 13.0(3.5-15.5)岁的患者。约一半的患者(n = 24,52.2%)有明确的 AKI 发展风险因素。13 名患者(28.3%)无尿,且所有患者均被归类为 AKI KDIGO 第 3 期(p < 0.001)。近四分之一(n = 10,21.7%)的患者需要肾脏替代治疗。约 60%的患者(n = 26)至少有一个后遗症,其中蛋白尿最为常见(n = 15,38.5%;中位数(P25-75)尿蛋白/肌酐比值 0.30(0.27-0.44)mg/mg),其次是肾小球滤过率(GFR)降低(n = 11,27.5%;中位数(P25-75)GFR 75(62-83)mL/min/1.73 m2)。
儿科 AKI 与显著的发病率相关,有发生蛋白尿和肾功能损害的潜力,对长期预后有重要影响。